Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: plight of the practicing neurologist.

× No keyword cloud information.

5 in total

Review 1. Interferon in relapsing-remitting multiple sclerosis.

Authors: G P Rice; B Incorvaia; L Munari; G Ebers; C Polman; R D'Amico; G Filippini
Journal: Cochrane Database Syst Rev Date: 2001

2. Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.

Authors: Tomas Uher; Kelly Fellows; Dana Horakova; Robert Zivadinov; Manuela Vaneckova; Lukas Sobisek; Michaela Tyblova; Zdenek Seidl; Jan Krasensky; Niels Bergsland; Bianca Weinstock-Guttman; Eva Havrdova; Murali Ramanathan
Journal: J Lipid Res Date: 2016-12-06 Impact factor: 5.922

3. The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.

Authors: D Paolicelli; M D'Onghia; F Pellegrini; V Direnzo; P Iaffaldano; V Lavolpe; M Trojano
Journal: J Neurol Date: 2013-02-17 Impact factor: 4.849

4. Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

Authors: A Bertolotto; S Malucchi; A Sala; G Orefice; P B Carrieri; M Capobianco; E Milano; F Melis; M T Giordana
Journal: J Neurol Neurosurg Psychiatry Date: 2002-08 Impact factor: 10.154

5. MxA gene expression analysis as an interferon-beta bioactivity measurement in patients with multiple sclerosis and the identification of antibody-mediated decreased bioactivity.

Authors: Andrew Pachner; Kavitha Narayan; Nicholson Price; Marie Hurd; Donna Dail
Journal: Mol Diagn Date: 2003

5 in total